erythromycin has been researched along with Guillain-Barre Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anagnostouli, M; Athanassaki, C; Chatzipanagiotou, S; Giannoulia, A; Kilidireas, K; Legakis, N; Nicolaou, C; Trimis, G; Youroukos, S | 1 |
Albuquerque, L; Brandão, T; Coelho, M; Freitas, P; Leite, A; Miranda, C; Revés, A; Serra, I | 1 |
2 other study(ies) available for erythromycin and Guillain-Barre Syndrome
Article | Year |
---|---|
Campylobacter jejuni O:19 serotype-associated Guillain-Barré syndrome in a child: the first case reported from Greece.
Topics: Antibodies, Bacterial; Autoantibodies; Campylobacter Infections; Campylobacter jejuni; Child; Erythromycin; Greece; Guillain-Barre Syndrome; HLA-B35 Antigen; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Immunoglobulins; Male; O Antigens | 2003 |
Mycoplasma pneumoniae causing nervous system lesion and SIADH in the absence of pneumonia.
Topics: Adult; C-Reactive Protein; Demyelinating Diseases; Erythromycin; Fever of Unknown Origin; Guillain-Barre Syndrome; Humans; Immunoglobulin G; Immunoglobulin M; Inappropriate ADH Syndrome; Male; Mycoplasma pneumoniae; Neurologic Examination; Pneumonia, Mycoplasma; Quadriplegia; Respiratory Insufficiency; Retrograde Degeneration | 2004 |